Clover Company Restricted (OTCPK:CLVCF) This fall 2025 Earnings Name September 22, 2025 8:01 PM EDT
Firm Contributors
Peter Davey – CEO, MD & Govt Director
Andrew G. Allibon – CFO & Firm Secretary
Convention Name Contributors
Apoorv Sehgal – UBS Funding Financial institution, Analysis Division
Mark Southwell-Keely – Choose Equities Pty Ltd.
Sam Pittman – Taylor Collison Restricted, Analysis Division
Presentation
Operator
Thanks for standing by, and welcome to the Clover Company Restricted FY ’25 Outcomes Briefing. [Operator Instructions]
I might now like at hand the convention over to Mr. Peter Davey, Managing Director and CEO. Please go forward.
Peter Davey
CEO, MD & Govt Director
Good morning, and thanks very a lot for becoming a member of us. Welcome to the Clover Company FY ’25 Outcomes Presentation. My title is Peter Davey, and I am the Managing Director and CEO of Clover. And with me is Andrew Allibon, Andrew is the CFO and Firm Secretary. And we’re more than happy to be taking you thru some excellent outcomes. So it is beautiful to be speaking to you once more this yr.
The primary slide takes us to only a little bit of an summary of the corporate. Clover is a worldwide chief within the microencapsulation of omega-3s, and we service the toddler system and meals market. We’re in toddler system. We’re in useful meals and beverage and prescription drugs and dietary supplements. And definitely, over the past 12 to 18 months, we have seen a major differentiation of our merchandise into different markets. Our manufacturing footprint is throughout Australia, New Zealand and Ecuador and later within the presentation, I am going to discuss you thru our vertical integration technique and the way that is servicing the enterprise.
We’ve got simply over 68 staff and we use vertical integration of the enterprise into different suppliers that present us with numerous companies. So it is a
